233 related articles for article (PubMed ID: 14598261)
1. Mesenteric vasoconstriction triggers nitric oxide overproduction in the superior mesenteric artery of portal hypertensive rats.
Tsai MH; Iwakiri Y; Cadelina G; Sessa WC; Groszmann RJ
Gastroenterology; 2003 Nov; 125(5):1452-61. PubMed ID: 14598261
[TBL] [Abstract][Full Text] [Related]
2. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW
Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203
[TBL] [Abstract][Full Text] [Related]
3. NO overproduction by eNOS precedes hyperdynamic splanchnic circulation in portal hypertensive rats.
Wiest R; Shah V; Sessa WC; Groszmann RJ
Am J Physiol; 1999 Apr; 276(4):G1043-51. PubMed ID: 10198349
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y restores non-receptor-mediated vasoconstrictive action in superior mesenteric arteries in portal hypertension.
Hartl J; Dietrich P; Moleda L; Müller-Schilling M; Wiest R
Liver Int; 2015 Dec; 35(12):2556-63. PubMed ID: 26010514
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of eNOS initiates excessive NO production in early phases of portal hypertension.
Iwakiri Y; Tsai MH; McCabe TJ; Gratton JP; Fulton D; Groszmann RJ; Sessa WC
Am J Physiol Heart Circ Physiol; 2002 Jun; 282(6):H2084-90. PubMed ID: 12003815
[TBL] [Abstract][Full Text] [Related]
6. Long-term octreotide treatment prevents vascular hyporeactivity in portal-hypertensive rats.
Sieber CC; Lee FY; Groszmann RJ
Hepatology; 1996 May; 23(5):1218-23. PubMed ID: 8621156
[TBL] [Abstract][Full Text] [Related]
7. Sepsis worsening vascular hyporeactivity of the superior mesenteric artery in portal vein-ligated rats.
Liao WC; Hou MC; Wang GJ; Yu KW; Lee FY; Lin HC; Lee SD
J Chin Med Assoc; 2010 Sep; 73(9):462-70. PubMed ID: 20875619
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide-dependent and -independent vascular hyporeactivity in mesenteric arteries of portal hypertensive rats.
Heinemann A; Wachter CH; Holzer P; Fickert P; Stauber RE
Br J Pharmacol; 1997 Jul; 121(5):1031-7. PubMed ID: 9222564
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Y1-receptor-mediated vasoconstrictive action of neuropeptide Y (NPY) in superior mesenteric arteries in portal hypertension.
Wiest R; Jurzik L; Moleda L; Froh M; Schnabl B; von Hörsten S; Schölmerich J; Straub RH
J Hepatol; 2006 Mar; 44(3):512-9. PubMed ID: 16324766
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of nNOS and associated increase in nitrergic vasodilation in superior mesenteric arteries in pre-hepatic portal hypertension.
Jurzik L; Froh M; Straub RH; Schölmerich J; Wiest R
J Hepatol; 2005 Aug; 43(2):258-65. PubMed ID: 15963596
[TBL] [Abstract][Full Text] [Related]
11. Effects of tumor necrosis factor, endothelin and nitric oxide on hyperdynamic circulation of rats with acute and chronic portal hypertension.
Wang JJ; Gao GW; Gao RZ; Liu CA; Ding X; Yao ZX
World J Gastroenterol; 2004 Mar; 10(5):689-93. PubMed ID: 14991939
[TBL] [Abstract][Full Text] [Related]
12. Hsp90 regulation of endothelial nitric oxide synthase contributes to vascular control in portal hypertension.
Shah V; Wiest R; Garcia-Cardena G; Cadelina G; Groszmann RJ; Sessa WC
Am J Physiol; 1999 Aug; 277(2):G463-8. PubMed ID: 10444461
[TBL] [Abstract][Full Text] [Related]
13. Droxidopa, an oral norepinephrine precursor, improves hemodynamic and renal alterations of portal hypertensive rats.
Coll M; Rodriguez S; Raurell I; Ezkurdia N; Brull A; Augustin S; Guardia J; Esteban R; Martell M; Genescà J
Hepatology; 2012 Nov; 56(5):1849-60. PubMed ID: 22610782
[TBL] [Abstract][Full Text] [Related]
14. Enhanced release of nitric oxide in response to changes in flow and shear stress in the superior mesenteric arteries of portal hypertensive rats.
Hori N; Wiest R; Groszmann RJ
Hepatology; 1998 Dec; 28(6):1467-73. PubMed ID: 9828208
[TBL] [Abstract][Full Text] [Related]
15. Deletion of inducible nitric oxide synthase decreases mesenteric vascular responsiveness in portal hypertensive mice.
Bexis S; Vandeputte C; McCormick PA; Docherty JR
Eur J Pharmacol; 2004 Sep; 499(3):325-33. PubMed ID: 15381055
[TBL] [Abstract][Full Text] [Related]
16. Atrophy of mesenteric sympathetic innervation may contribute to splanchnic vasodilation in rat portal hypertension.
Coll M; Martell M; Raurell I; Ezkurdia N; Cuenca S; Hernández-Losa J; Esteban R; Guardia J; Bosch J; Genescà J
Liver Int; 2010 Apr; 30(4):593-602. PubMed ID: 19968782
[TBL] [Abstract][Full Text] [Related]
17. Adrenal dysfunction in portal hypertensive rats with acute hemorrhage.
Lee FY; Wang SS; Tsai MH; Huang HC; Lin HC; Lee SD
PLoS One; 2014; 9(3):e92093. PubMed ID: 24633079
[TBL] [Abstract][Full Text] [Related]
18. Chronological changes in renal vascular reactivity in portal hypertensive rats.
Chuang CL; Huang HC; Chang CC; Lee FY; Wu JC; Lee SD
Eur J Clin Invest; 2013 Mar; 43(3):267-76. PubMed ID: 23293840
[TBL] [Abstract][Full Text] [Related]
19. Hyporeactivity of mesenteric resistance arteries in portal hypertensive rats.
Sogni P; Sabry S; Moreau R; Gadano A; Lebrec D; Dinh-Xuan AT
J Hepatol; 1996 Apr; 24(4):487-90. PubMed ID: 8738736
[TBL] [Abstract][Full Text] [Related]
20. Aliskiren reduces portal pressure in portal hypertensive rats.
Chang CC; Lee WS; Huang HC; Lee FY; Wang SS; Lin HC; Nong JY; Lee SD
Eur J Clin Invest; 2012 May; 42(5):526-33. PubMed ID: 22023532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
